Literature DB >> 16281460

Methodology of neuropsychological research in multicentre randomized clinical trials: a model derived from the International Subarachnoid Aneurysm Trial.

Richard B Scott1, Elly Farmer, Amanda Smiton, Caroline Tovey, Mike Clarke, Katherine Carpenter.   

Abstract

As advances in medicine and surgery lead to reductions in mortality rates for life-threatening conditions, it has become increasingly important to refine the methodology of auditing long-term morbidity. The inclusion of appropriate neuropsychological outcomes in a large multicentre randomized clinical trial poses considerable methodological and logistical difficulties. This paper presents a model developed to implement such a multicentre neuropsychological and quality of life audit for a subset of patients within the International Subarachnoid Aneurysm Trial (ISAT), the largest ever randomized trial in the treatment of subarachnoid haemorrhage. Based on our experience of collecting quality of life and neuropsychological outcomes from more than 550 patients, data are presented on the relative cost and efficacy of different organizational strategies, methods of canvassing patients and associated response rates. On the basis of this experience, we estimate a potential recruitment pool of 135 cases would be required to obtain some neuropsychological data on 100 cases. The design of any similar trial would therefore need to accommodate a loss to follow-up of approximately one third of the sample. In addition, our experience suggests that for a trial of this size and complexity, the deployment of centrally-based co-ordinators travelling to satellite centres is more cost-effective than employing co-ordinators based at those centres. Extrapolations from the observations and calculations reported here can be employed as an evidence base to inform the design of neuropsychological outcome studies in large multicentre trials.

Entities:  

Mesh:

Year:  2004        PMID: 16281460     DOI: 10.1191/1740774504cn008xx

Source DB:  PubMed          Journal:  Clin Trials        ISSN: 1740-7745            Impact factor:   2.486


  5 in total

1.  Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial.

Authors:  Adrian Williams; Steven Gill; Thelekat Varma; Crispin Jenkinson; Niall Quinn; Rosalind Mitchell; Richard Scott; Natalie Ives; Caroline Rick; Jane Daniels; Smitaa Patel; Keith Wheatley
Journal:  Lancet Neurol       Date:  2010-04-29       Impact factor: 44.182

2.  Construct validity, ecological validity and acceptance of self-administered online neuropsychological assessment in adults.

Authors:  Naomi S Chaytor; Celestina Barbosa-Leiker; Laura T Germine; Luciana Mascarenhas Fonseca; Sterling M McPherson; Katherine R Tuttle
Journal:  Clin Neuropsychol       Date:  2020-09-03       Impact factor: 3.535

3.  From multidimensional neuropsychological outcomes to a cognitive complication rate: the International Subarachnoid Aneurysm Trial.

Authors:  Richard B Scott; Fiona Eccles; Andrew Lloyd; Katherine Carpenter
Journal:  Trials       Date:  2008-03-14       Impact factor: 2.279

Review 4.  Design, implementation and reporting strategies to reduce the instance and impact of missing patient-reported outcome (PRO) data: a systematic review.

Authors:  Rebecca Mercieca-Bebber; Michael J Palmer; Michael Brundage; Melanie Calvert; Martin R Stockler; Madeleine T King
Journal:  BMJ Open       Date:  2016-06-15       Impact factor: 2.692

5.  The neuropsychological assessment battery (NAB) is a valuable tool for evaluating neuropsychological outcome after aneurysmatic subarachnoid hemorrhage.

Authors:  Johannes Walter; Martin Grutza; Lidia Vogt; Andreas Unterberg; Klaus Zweckberger
Journal:  BMC Neurol       Date:  2020-11-26       Impact factor: 2.474

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.